GuruFocus data shows that the President and CEO N/A purchased 4500 shares of TRACON Pharmaceuticals Inc. ( TCON) in 2022-04-21.
Insiders buying shares of stock in their companies can be a good sign. This could indicate that insiders have become optimistic about the company's future. It is worthwhile to pay attention to insider trades as they have a greater understanding of their company than most people. Let's now take a closer look at the insider purchase to determine if TRACON Pharmaceuticals Inc is worthy of investor attention.
Charles Theuer's Trades
Charles Theuer purchased total of 0 shares over the last year.
Charles Theuer is a long-term stockholder of their company. This could indicate that the stock is on the right track.
Trends from the inside
Investors may be unsure if the buys of one insider are really that significant. Is the stock being bought by other insiders or is it being sold?
Insider transactions history of TRACON Pharmaceuticals Inc shows that there were 22 insider buys over the last year. In the meantime, there were 0 insider sales in that same period.
Insider purchases are more appealing than insider sales to us. This is a sign of a positive trend in the company's owners and top executives. Insiders buying more stock means that it's more likely the stock will be undervalued.
Valuation
Charles Theuer recently bought shares of TRACON Pharmaceuticals Inc for $2.21 apiece. The stock now has a market capitalization of $42.667 million.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
